VAR2 Pharma will join BIO-Europe in Vienna between Nov 3-5. 

Our CEO Prof. Ali Salanti will present our company and program on Nov 3 at 14:15 in Theater 2. Ali will share data from our ongoing first-in-human imaging trial and how we are quickly translating the first of its kind antibody drug conjugate targeting oncofetal chondroitin sulfate to the clinic.